ESR1 and neoplasm: Previous exploratory analyses of multiple independent datasets have demonstrated that quantitative scoring of PR positive tumor cells (but not ER positive tumor cells) might predict BC outcome when an empiric cut-off of more than 20% for PR percentage to discriminate luminal A and luminal B-like was chosen (20).